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Abstract
Cancer progression is often driven by an accumulation of genetic changes but also accompanied by increasing genomic
instability. These processes lead to a complicated landscape of copy number alterations (CNAs) within individual tumors and
great diversity across tumor samples. High resolution array-based comparative genomic hybridization (aCGH) is being used
to profile CNAs of ever larger tumor collections, and better computational methods for processing these data sets and
identifying potential driver CNAs are needed. Typical studies of aCGH data sets take a pipeline approach, starting with
segmentation of profiles, calls of gains and losses, and finally determination of frequent CNAs across samples. A drawback of
pipelines is that choices at each step may produce different results, and biases are propagated forward. We present a
mathematically robust new method that exploits probe-level correlations in aCGH data to discover subsets of samples that
display common CNAs. Our algorithm is related to recent work on maximum-margin clustering. It does not require pre-
segmentation of the data and also provides grouping of recurrent CNAs into clusters. We tested our approach on a large
cohort of glioblastoma aCGH samples from The Cancer Genome Atlas and recovered almost all CNAs reported in the initial
study. We also found additional significant CNAs missed by the original analysis but supported by earlier studies, and we
identified significant correlations between CNAs.
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Introduction
Cancers are a complex set of proliferative diseases whose
progression, in most cases, is driven in part by an accumulation of
genetic changes, including copy number aberrations (CNAs) of
large or small genomic regions [1,2,3] which may for example lead
to amplification of oncogenes or loss of tumor suppressor genes.
However, cancer progression is also often characterized by
increasing genomic instability, potentially generating many
‘‘passenger’’ CNAs that do not confer clonal growth advantage.
These processes give rise to a complicated landscape of genomic
alterations within an individual tumor and great diversity of these
CNAs across tumor samples, making it difficult to identify driver
mutations associated with cancer progression.
In recent years, array-based comparative genomic hybridiza-
tion (aCGH) [4,5] and single nucleotide polymorphism (SNP)
arrays [6] have been used to analyze the CNAs of tumor samples
at a genomic scale and at progressively higher resolutions.
Moreover, numerous large-scale tumor profiling studies have
generated copy number data sets for large cohorts of tumors
[7,8]. These large and complex ‘‘cancer genome’’ data sets
present difficult statistical challenges [9]. Individual CNAs may
be as small as a few adjacent probes or as large as a whole
chromosomes and may be difficult to detect above probe-level
noise; moreover, it is unclear how to make sense out of diverse
CNAs from hundreds of tumors.
Typically, two kinds of analyses have been carried out on copy
number data sets:
1. clustering of samples by their CNAs, to determine possible
tumor subtypes characterized by a common pattern of
amplifications and deletions;
2. determining significant genetic aberrations, either gains or
losses, that occur frequently in the data set, since these may
represent driver mutations important for tumor progression.
Almost always, these problems are tackled with a pipeline
approach, where aCGH profiles of chromosomes for individual
samples are first processed by a segmentation algorithm; individual
segments (genomic regions) are ‘‘called’’ as gains or losses, based
on their amplitude, using a choice of statistical procedure and
significance threshold; and finally the called segments are used as
input to a clustering algorithm [1,10,11] or score-based method
for determining significant common aberrations [12,13,14]. The
disadvantage of pipeline approaches, however, is that algorithmic
choices and tuning parameters at each step may produce very
different results, and mistakes or biases are propagated forward.
For the first step, there are numerous segmentation algorithms
[15,16,17,18] that yield significantly different segment boundaries
[19], leading to different calls of gains and losses. The final step of
analyzing CNAs across samples depends critically on choices made
earlier. As an example, the widely-used GISTIC method for
determining frequent aberrations [12] uses as its test statistic, at
each locus, the number of samples in which a gain (or loss) is
present multiplied by the mean amplitude of the gain (loss).
However, both the count and the mean amplitude depend on
earlier choices in the pipeline.
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method for finding significant patterns of CNAs in a large copy
number data set directly from the probe-level data. By avoiding a
pipeline approach involving a segmentation step, our algorithm
exploits probe-level correlations in aCGH data to discover subsets
of samples that display common CNAs. By applying the approach
in a hierarchical fashion to iteratively partition the data set, we
discover both large- and small-scale events and can detect
statistically significant CNAs occurring on *5% of the samples.
In this way, the algorithm addresses both the clustering problem
and the frequent aberration problem at the same time.
Algorithmically, our approach is related to recent work on
maximum-margin clustering [20,21,22,23], which extends support
vector machine-like optimization approaches to the problem of
unsupervised clustering. That is, each partition of the data set is
achieved by learning a linear classifier of the probe-level aCGH
profiles that assigns samples to one group or the other. We also
build on ideas developed for supervised classification of aCGH
samples [24,25,26,27], in particular, the use of piece-wise constant
and lasso [17,26,28] regularization terms in the optimization
problem, which encourages the classifier to make decisions using
only a small number of probes in informative contiguous regions.
We tested our approach on a large cohort of glioblastoma
aCGH samples recently generated by The Cancer Genome Atlas
Project (TCGA) [7]. We found that the major CNAs detected by
our algorithm are largely consistent with the original TCGA study,
in that almost all CNAs previously reported were also in our
results. However, we found additional significant CNAs missed by
the TCGA analysis but supported by earlier studies and/or
expression analyses. Moreover, the hierarchical partitioning
approach summarizes the set relationships and dependencies
between different CNAs, which may be helpful for generating
hypotheses about the sequence of CNAs in tumor progression.
Results
Algorithm overview
Our algorithm iteratively partitions a data set of tumor aCGH
profiles for a given chromosome to discover subsets of tumors with
similar CNAs. Instead of using standard preprocessing techniques
like segmentation algorithms, we directly use probe-level data and
incorporate prior knowledge about the nature of this data, namely:
(1) successive probes are correlated, i.e. are likely to represent the
same copy numbers; and (2) a chromosome typically (though not
always) harbors few CNAs. At each partitioning step, we learn a
linear separator fw,b(x)~w:xzb that assigns aCGH profiles x to
one of two classes, represented geometrically by the two half-
spaces (i.e. fw,b(x)w0 and fw,b(x)v0) on either side of the
hyperplane defined by the normal vector w and bias term b
(Figure 1). Here, chromosome profiles x and the weight vector w
are real-valued vectors with dimension equal to the number of
probes for the chromosome, and w is determined by solving an
optimization problem (see Methods) where it is constrained to be
piecewise constant (successive probes tend to have the same
weights) and sparse (few probes have non-zero weights). Our
approach builds on a recently proposed maximum margin
clustering algorithm [21,22], which brings ideas from large-
margin supervised learning techniques like support vector machine
classification and support vector regression to the unsupervised
clustering problem; the choice of constraints was motivated by
recent work on fused lasso regression [28] (see Methods).
Since each linear separator results in a binary partition of
samples, we apply our procedure iteratively to separate each group
of samples into two new groups in such a way that the new linear
separator is orthogonal to the previously determined ones.
Therefore, each step will find a new direction of variation in the
aCGH data (similar to principal component analysis [29]), and the
overall procedure results in a hierarchical partitioning of the data
set (see Methods).
Large-margin partitioning reveals hierarchy of copy
number changes
We collected our data set from the Cancer Genome Atlas
(TCGA) data portal [7]. It contains 345 glioblastoma tumor
samples with copy number changes profiled on Agilent 244K
arrays (*228K probes). This data set has previously been
analyzed to determine major amplification and deletion events
using the RAE [13] and GISTIC [12] algorithms [7].
We used the Level 2 data already produced by the previous
analysis [7]. This data has already been normalized through the
application of a lowess algorithm on the log2 ratio data, and
probes flagged as low-quality (saturated, non-uniform or faint) are
excluded. Quality of the arrays was also measured through the
proportion of excluded probes and the consistency of values
associated with successive probes, and low-quality arrays were
removed from the data set.
We ran our algorithm separately on every chromosome, with a
sparseness coefficient l~20 and a piecewise-constantness coeffi-
cient m~2 (see Methods). Empirically, we found the following
dependence on the choice of these coefficients: if the coefficients
were chosen to be too small, it would result in a trivial clustering,
with all samples assigned to the same group; if the parameters were
too permissive, the clustering obtained would be the same as
standard k-means (k~2). However, between these two extremes,
clustering results were not overly sensitive to parameter choice. We
expect the suitable range of parameters to depend on the array
platform as well as statistical properties of the array profiles in a
given data set. We therefore suggest performing a grid search on a
subset of the samples and selecting the smallest possible
parameters that give a non-trivial clustering on every chromo-
some.
In order to assess the significance of our results, we used a
random model where we shuffled the probes of our dataset and
compared the distance between the median samples of our two
groups to the distribution of 1000 distances of median samples of
two random sample groups separated with the same classifier. We
verified that the randomized distance distribution follows a normal
distribution, and we computed the p-value for the distance
between the median samples corresponding to the tail of this
normal distribution.
For each chromosome, we constructed a ‘‘clustering tree’’ by
iteratively splitting each group into two if it respected three
criteria. The first criterion was that it must contain more than five
samples (*1.5% of the data set), since it would be difficult to
achieve a statistically significant partition of very small subsets.
The second criterion was that splitting this group would not make
the depth of our tree bigger than 3. The maximal depth was
chosen heuristically: after three iterations, we empirically found
that the groups were too small or the separation was not significant
anymore. The last criterion was that the partition generating this
group must satisfy a significance threshold of pv0:05. While this
p-value may seem overly permissive, it is important to understand
that our estimator (the centroid distance) is not directly optimized
by the algorithm; therefore, the empirical p-values generated are
fairly conservative.
Figure 2 gives an example of a ‘‘clustering tree’’ produced by
our algorithm for chromosome 19. The first iteration separates the
samples into two clusters, one with 17 samples that presents a
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pv0:04. The centroid of each cluster is shown in green (Figure 2,
leftmost column); in addition, a segmentation of each cluster
centroid using a standard tool (circular binary segmentation [30])
is shown to aid visualization of the copy number differences
between the two groups. As pv0:05 for this separation and each
cluster is bigger than 5 samples, we split each of these subsets into
two new groups. The splitting of the group of 17 samples is is not
associated with a significant enough median separation (pv0:7)
and therefore is not split again. On the other hand, the partition of
the group of 326 samples produces one group of 250 samples
without any apparent significant CNA and a group of 76 samples
whose centroid shows an amplification of the whole chromosome.
This split has strong significance (pv3|10{11), and therefore
both of these groups are split again. The partition of the group of
250 samples does not achieve significance (pv0:2), and neither of
the resulting clusters show any significant CNAs. The group of 76
samples is divided into two new groups of 37 and 39 samples
(pv7|10{3). Each of these groups shows an amplification of the
whole chromosome, but the group with 39 samples seems to have
a lower amplification of the q arm than of the p arm while the
other does not. As we limit ourselves to trees of depth 3, we do not
partition either of these groups any further.
Analysis of glioblastoma aCGH data recovers known
CNAs without segmenting samples
We applied the iterative procedure to each chromosome
independently, as described in the previous section. To call
Figure 1. Toy representation of a linear partition of aCGH samples using large-margin techniques. The algorithm finds a linear function
f(x)~w:xzb that is able to partition the aCGH samples into two groups. By solving an optimization problem, the algorithm determines the vector w,
which geometrically represents the normal vector of a hyperplane (shown in red) separating the samples, along with the bias term b, and the
assignment of samples to groups. In the toy example shown, the hyperplane separates the samples that present a deletion on the q arm (above the
hyperplane) from the ones that do not (below the hyperplane).
doi:10.1371/journal.pone.0012028.g001
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segmentation [30] using default parameters on its centroid, i.e. the
median profile of the cluster, and associated the characteristic
CNA(s) of this centroid to the cluster. One should understand that
the aberrations of the centroid profile may not be shared by every
one of the cluster samples, but that it gives a good estimate of these
events. We also caution that the size of the partition gives a good
idea of the penetrance but is not entirely equivalent.
The first iteration of our algorithm found an amplification of the
whole chromosome 1, of the whole chromosome 7 and of the
whole chromosome 20. It also identified the deletion of the whole
9p arm, as well as a big part of 19q, the whole chromosome 10, the
whole chromosome 13, the whole chromosome 14 and the whole
chromosome 22. The second iteration of the algorithm found the
loss of 6q arm, deletion of the whole chromosome 15, of the whole
chromosome 16 and an amplification of the whole chromosome
19. It also demonstrated that some samples that present an
amplification of chromosome 7 also contain a focal and very
strong amplification event on the 7p arm. The third iteration of
the algorithm identified focal amplification events on chromosome
3 and on chromosome 4. It also showed a loss of the whole
chromosomes 9 and 21. These results are summarized in Table 1,
along with the size of the partition in which each CNA was
identified in terms of number of samples and percentage of the full
data set.
An analysis of the same data set using both RAE [13] and
GISTIC [12] algorithms has already been published [7]. Both
methods agreed on significant large-scale amplification events for
the whole chromosomes 7, 19 and 20 and focal amplification
events on chromosome 1 and 12; significant large-scale deletion
events on chromosomal arms 6q, 9p, 15q, on whole chromosomes
10, 13, 14 and 22; and focal deletion events on chromosome 1. In
addition, RAE found significant focal amplification events on
chromosome 14, as well as significant focal deletion events on
chromosome 11. By contrast, GISTIC found different additional
focal amplification events on chromosomes 3 and 4. Figure 3
includes a summary of our results as well as a comparison with the
amplification and deletion events found by both of these analysis.
As shown in Figure 3, most of the events found in both RAE
and GISTIC analyses are found by the first two iterations of our
Figure 2. Clustering tree for chromosome 19. At each iteration of the algorithm, each previously identified group of samples are partitioned
into two new clusters used a maximum-margin clustering technique that exploits the correlations in aCGH profiles (see Methods). The partitioning
process stops when (i) a group has fewer than 5 samples; (ii) the partition generating the group fails to achieve a statistical significance threshold of
pv0:05; or (iii) the tree is already at the maximum depth of 3. In the picture above, each group is represented by its centroid, i.e. its median profile, in
green. For visualization purposes, the segmentation of the centroid, produced by circular binary segmentation [30], is shown in red.
doi:10.1371/journal.pone.0012028.g002
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methods. Exceptions include a small amplification event on
chromosome 12, the events on chromosome 1 (where our method
disagrees with the finding of RAE and GISTIC) and an
amplification event on chromosome 4, which is found on our
third iteration.
Iterative partitioning reveals novel CNAs supported by
independent glioblastoma studies
Beyond recovering almost all the CNAs identified by methods
like RAE and GISTIC, our iterative partitioning algorithm found
a number of significant events that were not discovered by
previous analyses of this dataset. These events include an
amplification of the whole chromosome 1, a deletion event on
the whole chromosomes 9, 15, 16 and 21, as well as a deletion of
the 19q arm.
Some of these events have been documented in studies of
independent copy number data sets, such as the deletion on the
19q arm [31,32] and of chromosome 16 [33]. The deletion of
chromosome 21 has been previously associated with glioblastoma
[34], and it has been proposed that the low incidence of
glioblastoma in Down’s syndrome patients is linked to the
chromosome 21 trisomy that characterizes this genetic condition
Table 1. Summary of significant events in glioblastoma data set.
Event Iter. # of samples % of samples Size of event Correlated genes Examples of candidate genes
(a) Chr. 1 1 26 7.5% 247 Mbp 170=2101 LCK, PAX7, RPL22
(a) 3q26.1 3 6 1.7% 25 Kbp 2=11
(a) 4q12 3 7 2.0% 236 Kbp 19=40 CHIC2, FIP1L1, KIT, PDGFRA
(d) 6q 2 31 9% 110 Mbp 239=470 FOXO3A
(a) Chr. 7 1 169 49% 158 Mbp 493=984 BRAF, CDK6, EGFR, ELN, HIP1, PMS2,
SMO, TIF1
(a) 7p11.2 2 76 22% 37 Kbp 11=22 EGFR
(d) 9p 1 99 29% 47 Mbp 111=221 CDKN2A- p14ARF, CDKN2A -
p16(INK4a),FANCG, JAK2, MLLT3, PSIP2
(d) Chr. 9 3 7 2% 140 Mbp 0=785
(d) Chr. 10 1 154 45% 135Mbp 397=785 BMPR1A, D10S70, MYST4, NCOA4, PTEN,
SSH3BP1
(d) Chr. 13 1 61 18% 114Mbp 187=371 ERCC5, FOXO1A, LHFP, RB1, ZNF198
(d) Chr. 14 1 165 48% 106Mbp 333=658 AKT1, BCL11B, DICER1, GPHN, KTN1,
TCL1A, TCL6, TSHR
(d) Chr. 15 2 21 6.1% 100 Mbp 298=592 BLM, CRTC3, NTRK3, PML
(d) Chr. 16 2 15 4.3% 88.8 Mbp 408=802 CBFB, CDH1, CREBBP, CYLD, HERPUD1,
IL21R, CDH11, MAF, MHC2TA, MYH11,
TNFRSF17
(d) 19q13.2–
19q13.43
1 17 4.9% 25.2 Mbp 230=452 BCL3, ERCC2, TFPT, ZNF331
(a) Chr. 19 2 76 22% 63.8 Mbp 621=1249 AKT2, BCL3, BRD4, CIC, ELL, ERCC2,
KLK2, SH3GL1, STK11, TCF3, TFPT, TPM4,
ZNF331
(a) Chr. 20 1 74 21% 62.4 Mbp 285=570 ASXL1, GNAS, SS18L1, TOP1
(d) Chr. 21 3 6 1.7% 46.9 Mbp 117=231 ERG, RUNX1, DSCR1
(d) Chr. 22 1 300 87% 49.7 Mbp 40=525 CTCL1, EWSR1, MKL1, SMRCB1, ZNF278
We indicated the iteration in which the event was found as well as the number of samples that were assigned to this cluster and the percentage of the total number of
samples this represented. Deletions are denoted by the symbol (d) and amplifications by the symbol (a). Region names in boldface denote novel CNAs that were not
found by previous analyses while underlined regions represent short events. Candidate genes denote significantly differentially overexpressed genes in this region if the
CNA is an amplification and significantly differentially underepxressed genes in this region if the CNA is a deletion, according to a SAM analysis and out of the total
number of genes in the region.
doi:10.1371/journal.pone.0012028.t001
Figure 3. Comparison of the gains and losses found by iterative partitioning versus previous analyses. The horizontal tracks show the
CNAs identified by first three iterations of our method, compared to the ones found by GISTIC and RAE. The middle track depicts the chromosomes,
with even chromosome numbers annotated. Gains are denoted in red and losses in blue.
doi:10.1371/journal.pone.0012028.g003
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very small cluster (6 samples), and the low frequency presumably
explains why this aberration was missed by previous analyses. The
deletion of chromosome 15 actually includes the deletion on the
15q arm found in the previous analyses. The shape of the centroid
for this partition shows that the amplitude of the deletion is smaller
on the rest of the q arm and on the p arm, and it is possible that
full chromosome deletion was not found by RAE or GISTIC due
to the smaller amplitude.
To identify genes that are well correlated with the CNAs, we
performed a significance analysis of microarray (SAM) using the
SAMR package. For each cluster, we labeled each sample
according to its label (inside or outside the cluster of interest)
and looked at the number of genes of the region of the CNA that
were significantly differentially underexpressed in the case of a
deletion, or significantly overexpressed in the case of an
amplification. Calculations were done using the t-statistic, 100
permutations and the Tusher method [36].
Our results, summarized in Table 1, show that in most cases a
large number of genes had expression levels that are significantly
correlated with the assignment of samples to the cluster harboring
the CNA. It should be noted that the relationship between
expression and copy number is complex, and that the absence of
significant correlations does not exclude the presence of the CNA,
especially in cases where the low count of genes or samples makes
this correlation statistically difficult to prove.
The novel CNAs discovered by our analysis are correlated with
several important genes. For example, the deletion of the
chromosome 16, the 19q13.2–19q13.43 regions, and the chromo-
some 21 are significantly correlated with underexpression of
candidate cancer-suppressor genes, respectively CBFB [37,38] or
CDH11 [39], TFPT [40] and DSCR1 [35], giving additional
evidence in support of these events.
Several sets of frequent chromosomal aberrations show
high correlation
One advantage of our method compared to score-based
approaches such as RAE and GISTIC is that it gives an
assignment of samples to groups – or, more precisely, identifies
CNAs by simultaneously finding the groups of samples that harbor
them – which makes it easier to identify which samples are affected
by which frequent CNAs. We associated each sample to a set of
frequent CNAs based on its cluster assignments in the chromo-
some-based iterative partitioning procedure. We found that co-
occurrences of frequent CNAs within a sample were common;
indeed, a majority of samples (249 out of 345) contained 2 or more
of the frequent CNAs listed in Table 1.
We further examined co-occurrences of pairs of frequent CNAs,
and we found that 31 pairs can be considered correlated (i.e. with
an intersection of sample assignment better than expected by
background frequencies) with pv10{10 by Fisher’s exact test (see
Supplementary Figure S1).
A simple analysis of these significant pairs revealed that these
correlated CNAs can actually be seen as three groups of co-
occurences:
1. The amplification of chromosome 7 and its associated focal
amplification event, the deletion on 9p, the deletion of
chromosomes 10, 13 and 14 as well as the amplifications on
chromosomes 19 and 20 are all highly correlated.
2. The deletion of 6q is well correlated with the focal
amplification event on chromosome 7 as well as with the
deletion on 9p.
3. The deletion on chromosome 22 is well correlated with the
amplification of chromosome 7 (but not with the associated
focal event), the deletion of chromosome 10 and the deletion of
chromosome 14.
Discussion
Recovery of CNAs missed by summary statistics
Some of the novel glioblastoma CNAs that we found are good
examples of how our method improves on summary statistic
approaches, such as RAE and GISTIC. For instance, the deletion
of chromosome 15 has only been spotted on the q arm by RAE
and GISTIC. When we examined the profile of the centroid of a
cluster identified by our method, we saw a lower amplitude
deletion on the p arm as well. Because of this low amplitude, each
probe on its own would not have a significant mean deletion across
the data set and would hence be missed by a summary statistic.
However, because all of the probes for the chromosome are
affected, the deletion should be considered a significant CNA and
is readily identified by approach.
As a second example, the deletion of the region 19q2–19q13.3
has not been found by other methods applied to the TCGA data
set, even though it has been confirmed as a deletion event by
previous studies. Here, the problem seems to be the fact that the
same region is also present as an amplification event on a larger
number of samples, which confounds the detection of this deletion
by a summary test statistic. Finally, the deletion of the whole
chromosome 21 is presumably missed by other methods because it
is presents on only a small number of samples (6 samples or *2%).
However, since this event is a deletion of the whole chromosome
and therefore supported on many probes, intuitively it should be
much more statistically significant that a smaller but similarly
infrequent event. Indeed, the importance of this CNA is confirmed
by previous studies linking trisomy 21 in Down’s syndrome to
lower prevalence of glioblastoma as well as by the correlation with
the under-expression of a candidate tumor-supressor gene present
in this region.
Recovery of focal events
Figure 3 shows that even though the first iteration of our
algorithm seems to focus on large aberrations, the following
iterations are able to find focal events such as the ones on
chromosomes 3 and 4, and that our algorithm is therefore able to
find focal events as well as large ones. The only focal event whose
presence is agreed on by both RAE and GISTIC and that our
method is not able to find is the one on chromosome 12. Looking
at the raw data shows us that this event is shared by roughly 40
samples but only affects 2 probes, which makes it a difficult signal
to find when looking a multiple probes. However, by restricting
our analysis to a small interval centered on the event (*300kbp or
40 probes), we were able to identify the common event using our
maximum-margin clustering algorithm (see Supplementary Figure
S2), suggesting that our method could perhaps be used in
conjunction with a sliding window to improve detection of very
small events.
Analysis of samples with high noise and genomic
instability
The glioblastoma copy number profiles that we analyzed here
have relatively few CNA events and therefore provide a favorable
test case for computational analysis. Copy number data sets for
other cancers have proven far more problematic. For example, a
recent copy number study of lung adenocarcinoma [8] compiled a
Patterns of CNAs in Cancer
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signal to noise varied considerably over samples – potentially due
to stromal contamination – and a sizable fraction of samples
displayed numerous events. The authors curated the samples into
three tiers based on signal quality and restricted analysis to the best
tier. Despite the large average number of events per samples, the
study identified only a few regions altered in a significant number
of samples, with the most common CNA (amplification of
chromosome 14q13.3) only present in *12% of the best third
(top tier) of their samples. We applied our method to this lung
adenocarcinoma data set to see how it would perform in a high
noise setting. Since the original assignment of samples to tiers was
not readily available, we did a first pass analysis of the entire data
set – without attempting to reduce to the cleanest samples – using
the same parameters as we used on the TCGA data set.
Interestingly, the first iteration of the algorithm partitioned each
chromosome into two clusters containing exactly the same samples
(with pv10{5), with one group consisting of samples with a strong
but very noisy signal and the other containing samples with a weak
signal. This result suggests that our method may be able to
automatically distinguish signal quality.
The initial choice of parameters did not find any significant
aberrations at a p-value cutoff of 0.05, possibly due to the different
array platform as well as the different statistical properties of the
copy number profiles (see Supplementary Figure S3 and
Supplementary Table S1). However, using our algorithm with a
different set of parameters (l~1 and m~0:1) on chromosome 14
allowed us find the amplification of 14q13.3, albeit only in 6
samples (2% of the total count of samples) and with a weak p-value
(pv0:1). Here, the presence of a large group of very noisy samples
in the data set may be responsible for degrading the p-value. While
we were not able to directly compare to the original analysis on the
top tier samples, this quick analysis on the full data set is fairly
encouraging, in that we were able to retrieve the main result
without an ad hoc curation of samples.
Possible algorithmic extensions
The above analysis also underscores the impact of the choice of
the two constraint parameters, l and m (see Methods), which
determine the degree of sparseness and piecewise-constantness,
respectively, of our linear classifiers. We chose the parameters for
the glioblastoma study through heuristics and recovered most
known events as well as several novel and plausible CNAs.
However, full exploration of this parameter space could yield
additional results; for example, to predispose the algorithm to find
focal events, one might try to make the sparsity constraint more
stringent. Various strategies might be used to optimize the choice
of parameters, including use of a cross-validation loop. To
implement this approach, one would have to choose an
appropriate method for estimating the quality of the clusters:
standard estimators are closely tied to the objective functions
optimized by traditional clustering algorithms (such as K-means),
which do not take into account the properties of copy number
profiles (i.e. spatial correlations, sparsity of deletion/amplication
events). However, such a cross-validation loop would also entail
lengthier computational times. This cost could be greatly
reduced if we were able to compute the entire regularization
path of the fused lasso in a single pass, as others were able to
do with the original lasso [41] and SVM [42] optimization
problems.
An interesting direction for future research would be to extend
this method to incorporate gene expression data in the analysis of
copy number profiles. The candidate gene results of Table 1 show
that even a simple analysis is able to find significant correlations
between the two types of data. Presumably, CNAs that result in
deregulated expression are more likely to be driver mutations. A
framework that integrates paired copy number and mRNA
expression may yield greater insight into functional gains and
losses in cancer.
Conclusions
We have introduced a new mathematically sound method for
the identification of frequent alterations in a large cohort of tumor
copy number profiles. This method builds on the concept of
maximum-margin clustering by extending to more than two
groups and incorporating specific properties of copy number data,
i.e. the piecewise-constantness and the sparsity of CNAs.
We applied this method to a large publicly available
glioblastama data set from The Cancer Genome Atlas initiative.
Our results include most CNAs already found by previous studies
as well as novel CNAs confirmed by other data sets or expression
analyses. We showed that we were able to identify large
aberrations as well as focal events and found significant
correlations between these different CNAs.
Methods
Below, we briefly develop the technical background related to
our approach and describe the details of our algorithm. We first
present the fused lasso classification algorithm and then show how
to extend it to an unsupervised setting based on the maximum
margin clustering algorithms. Finally, we introduce our iterative
partitioning procedure for determining hierarchical clusters
characterized by common CNAs.
Supervised classification
We first consider the supervised learning problems for aCGH
profiles. Here we are given a training set of aCGH samples
fxigi[1...n of dimension p, where p is the number of probes; each
example xi has an associated label or an explanatory variable
yi [Y, where the labels can be discrete (classification) or real-
valued (regression).
Given our labeled set of samples, the goal of linear supervised
classification or regression is to build a linear function
fw,b(x)~w:xzb that will be able to predict the correct
explanatory variable y[Y for a new sample x[R
p. We use a
general formulation of supervised learning as an optimization
problem:
argmin
w,b
X n
i~1
L(fw,b(xi),yi)
under the constraint V(w)ƒl
ð1Þ
where L is a loss function that penalizes the error between the
predictions fw,b(xi) and the real explanatory variables yi, V is a
regularization function, and l[R the value of the constraint, to be
adjusted to find a suitable compromise between minimizing of the
error term and regularizing (avoiding overfitting) the model.
Problem (1) describes a whole family of algorithms that includes (i)
the support vector machine (SVM), when Y~f{1,1g is the set of
binary labels, L is the hinge loss L(fw,b(x),y)~max(0,1{yfw,b(x)),
and V is the Euclidean norm; (ii) the L1-SVM, when Y is the set
of binary labels, L is the hinge loss, and V the L1-norm; or (iii)
lasso regression, when Y~R, L is the squared error
L(fw,b(x),y)~(y{fw,b(x))
2,a n dV is the L1-norm; among many
others.
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Recently Xu et al. proposed to generalize this optimization
framework to the unsupervised clustering problem, i.e. trying to
find the best linear separator between (latent) classes of samples
when the labels are not known [21]. The general optimization
problem described in (1) then becomes
argmin
w,b,yi
X n
i~1
L(fw,b(xi),yi)
under the constraint V(w)ƒl
ð2Þ
However, in the case of binary classification, i.e. Y~f{1,1g,
Problem (2) becomes a mixed integer problem (MIP), which is not
easily solvable using standard optimization techniques. Instead,
Zhang et al. proposed an algorithm similar to conjugate descent to
solve this problem [22], alternating between (a) training the linear
separator given current label assignments and (b) updating the
label assignment based on the linear separator. They found that a
standard support vector machine (SVM) converges quickly in this
alternating procedure to a fixed set of labels without finding more
favorable cluster assignments. Therefore, they proposed using
support vector regression (SVR) for the linear separator. SVR is
more often used in the case of regression, i.e. Y~R, than in
binary classification but performs well for the clustering problem.
Incorporating prior knowledge
In choosing the regularization function V to use in training a
linear separator, we want to take into account two different
properties of copy number profiles:
1. Successive probes on the same chromosomes are likely to
represent the same copy number and should therefore tend to
be attributed similar weights in the linear function.
2. There are usually only a small number of CNAs in a given
sample, often (but not always) occupying relatively small
genomic regions, and therefore only a small number of probes
should have non-zero weights in the linear function.
Tibshirani and Saunders introduced a fused lasso method for
regression and classification that gives a sparse and piecewise-
constant linear function by imposing two separate constraints [28];
the regression formulation takes the form:
argmin
w,b
L(fw,b(xi),yi)
such that
X p
k~1
DwkDƒl
X p{1
k~1
Dwk{wkz1Dƒm
ð3Þ
where L is the least squares loss function. Here, the first constraint
is the lasso regularizer, which induces sparsity, i.e. few components
wk in the solution vector w are non-zero; the second constraint
enforces piecewise constantness, i.e. adjacent probes tend to be
assigned the same weight.
In the case of high-density copy number profiles, another issue is
the non-uniform distribution of the distances between successive
probes [43]. Older low resolution aCGH technologies used probe
sets designed to have relatively uniform inter-probe distances, or at
least, these distances varied within an order of magnitude. New
higher resolution technologies have higher disparities in inter-
probe distances. To take these into account, we modify the
constraints to include a coefficient that normalizes for inter-probe
distances:
argmin
w,b
X n
i~1
Eyi{fw,b(xi)E
2
s:t:
X p
k~1
DwkDƒl
X
k*l
aklDwk{wlDƒm
ð4Þ
where k*l if k and l refer to succesive positions on the same
chromosomal arm and akl is the weight of the corresponding
relation.
In the case of aCGH profiles, we define akl as
akl~log(
dkl
minq,rdqr ) ð5Þ
where dkl is the genomic distance between probes k and l.
Incorporating these modifications, we obtain the following
quadratic problem under linear constraints:
argmin
w,b
X n
i~1
a2
i , satisfying :
Vi~1,:::,n : ai§yi{wTxi{b
Vi~1,:::,n : ai§{yizwTxizb
X p
k~1
b
kƒl
Vk~1,:::,p : b
k§wk
Vk~1,:::,p : b
k§{wk
X
k*l
cklƒm
Vk, l such that k*l : ckl§akl(wk{wl)
Vk, l such that k*l : ckl§akl({wkzwl)
ð6Þ
Using this quadratic problem, we propose an algorithm similar
to the maximum margin clustering algorithm [22]:
Algorithm 1. Iterative fused lasso.
1. Initialize the labels fyig, for example with standard K-means
(K~2).
2. Calculate the linear separator w obtained by solving Problem
(4).
3. Assign the labels using the linear separator: yi~sign(wTxizb).
4. Repeat steps 2–3 until convergence.
Iterative partitioning
One limitation of the method proposed in Problem (4) is that it
only achieves a binary partition of the data, while in fact there may
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In order to overcome this limitation, we use the following iterative
partitioning algorithm:
Algorithm 2. Iterative partitioning.
1. Initialize the partition of the data with Algorithm 1.
2. Partition each of the groups of the partition into two new
groups.
3. Repeat steps 2 until the size of a new group or the significance
of the partition falls below threshold.
In order to guarantee that the newly discovered groups at each
step will explore different directions of variation, we make each
classifier orthogonal to the preceding ones. This can be done by
the following equation, assuming that we know the classifiers
fw0,:::,wjg, we can then learn a new classifier (and associated
partitioning) wjz1, written as w to simplify notation:
argmin
w,b
X n
i~1
Eyi{(wTxizb)E
2
s:t:
X p
k~1
DwkDƒl
X
k*l
aklDwk{wlDƒm
Vt[0...j : wT
t w~0
ð7Þ
where n is the number of samples that we want to separate.
Using the same method as in the last section, Problem (7) can be
transformed into a quadratic problem under linear constraints.
Implementation
The method has been implemented under Matlab using the
commercial Tomlab/CPLEX [44] package. Both this implemen-
tation and another one using the free SeDuMi [45] package are
freely available.
Supporting Information
Figure S1 Correlation matrix of frequent CNAs. The heatmap
shows the significance of the correlation between pairs of CNAs in
the TCGA glioblastoma data by displaying the p-value (Fisher’s
exact test) on a logarithmic scale. Every pair with p,1e-10 is given
the same color. The size of each square is proportional to the size
of the corresponding CNA (on a logarithmic scale).
Found at: doi:10.1371/journal.pone.0012028.s001 (2.08 MB TIF)
Figure S2 Analysis around the short event on chromosome 11 in
the TCGA glioblastoma data set. We performed our clustering
algorithm on a small region of ,300kbp (or 38 probes) centered
around the small deletion event found by RAE and GISTIC on
chromosome 11. The heatmap shows the value of the probes of
the samples on this region, with green indicating negative values
and red indicating positive values. The vertical axis represents the
sequence of probes along the genome, while the different samples
are shown on the horizontal axis. The blue and yellow color bars
correspond to the labels of each sample as determined by the first
iteration of our algorithm. These labels are perfectly correlated
with the presence of the bright green deletion event.
Found at: doi:10.1371/journal.pone.0012028.s002 (1.85 MB TIF)
Figure S3 Centroids of chromosome 14 clusters on the lung
adenocarcinoma dataset. The figure shows the two centroids of the
clusters found with the first iteration of our method on
chromosome 14 in the lung adenocarcinoma data set. The larger
probe signal amplitude and variance of the blue centroid
(corresponding to the smaller group) show that this cluster’s
samples have stronger signal than the other cluster (see also
Supplementary Table S1).
Found at: doi:10.1371/journal.pone.0012028.s003 (0.71 MB TIF)
Table S1 Variance of the lung aCGH profiles. We present the
mean probe signal variance of the samples of each cluster found at
the first iteration on the lung adenocarcinoma data set, compared
to the corresponding mean variance of clusters for the TCGA data
set. As described in the main text, the lung clusters for different
chromosomes always contain the same samples. The table shows
that the cluster variance is also surprisingly regular, and that the
the smaller group variance is especially big.
Found at: doi:10.1371/journal.pone.0012028.s004 (0.04 MB
PDF)
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